Pramipexole for Depression: A Different Approach When Antidepressants Fall Short
What is Pramipexole?

What is Pramipexole?
Pramipexole is a medication that has been used for Parkinson’s Disease and Restless Legs Syndrome. Recently it has gained interest as a potential treatment for depression. Pramipexole has been sold under the brand name Mirapex. Pramipexole was approved for use in the United States in 1997. It is currently available as a generic medication. In 2020 it was the 193rd most prescribed medication in the US (United States).
Mechanism of Action
Pramipexole works on several dopamine receptors as an agonist (or activator). It works as a full agonist at the D2s receptor and a partial agonist at the D2L, D3, and D4 receptors. This mechanism of action is unique in the treatment of depression. Activation of dopamine receptors has been shown to improve depressive symptoms in medication like Wellbutrin (bupropion) that increase the levels of dopamine.
Evidence For Use of Pramipexole for Treatment Resistant Depression
Below is a list of references from credible sources for the use of Pramipexole as an antidepressant:
“Conclusion: Our study found some evidence for an effect of pramipexole for the treatment of major depressive episodes.”
Tundo, A., de Filippis, R., & De Crescenzo, F. (2019). Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 140(2), 116–125. https://doi.org/10.1111/acps.13055
“Pramipexole is a promising augmentation agent for TRD (Treatment Resistant Depression) and may be a useful addition to existing treatment regimes.”
Au-Yeung, S. K., Griffiths, J., Roberts, S., Edwards, C., Yu, L.-M., Bogacz, R., Rendell, J., Attenburrow, M.-J., Watson, S., Chan, F., Cipriani, A., Cleare, A., Harmer, C. J., Kessler, D., Evans, J., Lewis, G., Singh, I., Simon, J., Harrison, P. J., & Cowen, P. (2022). PAX- D: study protocol for a randomized placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression. Evidence-Based Mental Health, 25(2), 77–83. https://doi.org/10.1136/ebmental-2021-300282
“Pramipexole (Mirapex) in combination with mood stabilizers may be a safe and effective treatment for patients with bipolar depression, a recent pilot study concluded. This agent, a novel dopamine agonist indicated for the treatment of patients with Parkinson's disease, may provide an alternative to standard antidepressants for treating bipolar patients who are not responding clinically or are susceptible to drug-induced mania or cycle acceleration. One patient taking pramipexole with divalproex developed mania with psychosis at week 6 and discontinued the study. “
Pramipexole for treatment-resistant bipolar depression. (2004). Brown University Psychopharmacology Update, 15(4), 3.
“Conclusions: These preliminary data suggest that pramipexole adjunction to antidepressant treatment may be effective and well tolerated in patients with resistant major depression.”
Lattanzi, L., Dell’Osso, L., Cassano, P., Pini, S., Rucci, P., Houck, P. R., Gemignani, A., Battistini, G., Bassi, A., Abelli, M., & Cassano, G. B. (2002). Pramipexole in treatment-resistant depression: a 16-week naturalistic study. Bipolar Disorders, 4(5), 307–314. https://doi.org/10.1034/j.1399-5618.2002.01171.x
“Our findings indicate that pramipexole augmentation therapy may be effective and well tolerated in refractory depressed patients.”
Hori, H., & Kunugi, H. (2012). The efficacy of pramipexole, a dopamine receptor agonist, as an adjunctive treatment in treatment-resistant depression: an open-label trial. TheScientificWorldJournal, 2012, 372474. https://doi.org/10.1100/2012/372474
“Conclusion: These preliminary data suggest that the addition of pramipexole to antidepressant treatment may be effective and well tolerated in patients with stage 2 treatment-resistant major depressive disorder.”
Inoue, T., Kitaichi, Y., Masui, T., Nakagawa, S., Boku, S., Tanaka, T., Suzuki, K., Nakato, Y., Usui, R., & Koyama, T. (2010). Pramipexole for stage 2 treatment-resistant major depression: an open study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34(8), 1446–1449. https://doi.org/10.1016/j.pnpbp.2010.07.035
Possible Advantages Over Current Antidepressants
It is possible that pramipexole has a rapid antidepressant effect. This would be advantageous over current treatments that take weeks to months to take effect. Dopamine is often tied to motivation and energy thus pramipexole may help with the fatigue and apathetic symptoms that are experienced in major depressive disorder. Pramipexole has a completely different mechanism of action from current antidepressants. Meaning that if you have failed antidepressants in the past, this may yet be an option for you.
Side Effects and Possible Disadvantages
Pramipexole has a wide array of side effects comparable to a lot of antidepressants. It still can have negative effects on libido and erectile function. Common side effects of pramipexole include Headache, Peripheral edema, Hyperalgesia (body aches and pains), Nausea, vomiting, Sedation, fatigue, decreased appetite and subsequent weight loss, Orthostatic hypotension, Insomnia, hallucinations, amnesia and confusion, twitching, twisting, or other unusual body movements, unusual tiredness or weakness, Impulsive-compulsive behaviors.
The Anxious Resistance Take on Pramipexole for Depression
Pramipexole shows a lot of promise for the treatment of depression. It has substantial evidence of its use in this way. It has a unique mechanism of action. Pramipexole is a medication available on the market and can be prescribed off-label now for depression treatment. All these things combined make it one of the best off-label options for depression currently available. Only a couple of medications reviewed by The Anxious Resistance show this kind of promise. Talk with your doctor if this is a medication you are interested in. Show them the evidence and explain its use in this way.
Words worth knowing
Insomnia
A sleep disorder involving persistent difficulty falling asleep, staying asleep, or getting restorative sleep.
